{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T10:24:10Z","timestamp":1787739850014,"version":"build-2784847793"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T00:00:00Z","timestamp":1681257600000},"content-version":"vor","delay-in-days":101,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Formosan Medical Association"],"published-print":{"date-parts":[[2023]]},"DOI":"10.1016\/j.jfma.2023.04.004","type":"journal-article","created":{"date-parts":[[2023,4,27]],"date-time":"2023-04-27T15:38:47Z","timestamp":1682609927000},"page":"S65-S73","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"S1","title":["Refracture risk and all-cause mortality after vertebral fragility fractures: Anti-osteoporotic medications matter"],"prefix":"10.1016","volume":"122","author":[{"given":"Ta-Wei","family":"Tai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Lun","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5520-5623","authenticated-orcid":false,"given":"Chien-An","family":"Shih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Chun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin-Fan","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6265-5155","authenticated-orcid":false,"given":"Chun-Feng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tien-Tsai","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1979-6160","authenticated-orcid":false,"given":"Jawl-Shan","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsung-Hsueh","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0504-2053","authenticated-orcid":false,"given":"Chih-Hsing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.jfma.2023.04.004_bib1","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.21106","article-title":"Prevalence of osteoporosis and fracture in China: the China osteoporosis prevalence study","volume":"4","author":"Wang","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"3","key":"10.1016\/j.jfma.2023.04.004_bib2","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1359\/jbmr.061113","article-title":"Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025","volume":"22","author":"Burge","year":"2007","journal-title":"J Bone Miner Res"},{"issue":"5","key":"10.1016\/j.jfma.2023.04.004_bib3","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s00198-006-0292-x","article-title":"Hospitalised osteoporotic vertebral fractures in Spain: analysis of the national hospital discharge registry","volume":"18","author":"Bouza","year":"2007","journal-title":"Osteoporos Int"},{"issue":"9","key":"10.1016\/j.jfma.2023.04.004_bib4","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1359\/jbmr.1998.13.9.1468","article-title":"Falls among community-dwelling elderly in Japan","volume":"13","author":"Aoyagi","year":"1998","journal-title":"J Bone Miner Res"},{"issue":"26","key":"10.1016\/j.jfma.2023.04.004_bib5","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1056\/NEJM198606263142605","article-title":"Involutional osteoporosis","volume":"314","author":"Riggs","year":"1986","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.jfma.2023.04.004_bib6","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/BF01623271","article-title":"Prevalence and incidence of vertebral deformities","volume":"3","author":"Melton","year":"1993","journal-title":"Osteoporos Int"},{"issue":"1","key":"10.1016\/j.jfma.2023.04.004_bib7","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jocd.2015.08.004","article-title":"Epidemiology of vertebral fractures","volume":"19","author":"Schousboe","year":"2016","journal-title":"J Clin Densitom"},{"issue":"1","key":"10.1016\/j.jfma.2023.04.004_bib8","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1186\/s12891-018-2171-y","article-title":"The prevalence and under-diagnosis of vertebral fractures on chest radiograph","volume":"19","author":"Li","year":"2018","journal-title":"BMC Muscoskel Disord"},{"issue":"1","key":"10.1016\/j.jfma.2023.04.004_bib9","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s11657-022-01098-6","article-title":"Incidence of different types of subsequent fractures and related mortality in Taiwan","volume":"17","author":"Chen","year":"2022","journal-title":"Arch Osteoporosis"},{"issue":"7","key":"10.1016\/j.jfma.2023.04.004_bib10","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1007\/s00198-011-1833-5","article-title":"Mortality after vertebral fracture in Korea: analysis of the national claim registry","volume":"23","author":"Lee","year":"2012","journal-title":"Osteoporos Int"},{"issue":"2","key":"10.1016\/j.jfma.2023.04.004_bib11","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s00198-003-1516-y","article-title":"Excess mortality after hospitalisation for vertebral fracture","volume":"15","author":"Kanis","year":"2004","journal-title":"Osteoporos Int"},{"issue":"1","key":"10.1016\/j.jfma.2023.04.004_bib12","first-page":"44","article-title":"Diagnosis and management of vertebral compression fractures","volume":"94","author":"McCarthy","year":"2016","journal-title":"Am Fam Physician"},{"issue":"7","key":"10.1016\/j.jfma.2023.04.004_bib13","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S2213-8587(17)30138-9","article-title":"10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension","volume":"5","author":"Bone","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"1","key":"10.1016\/j.jfma.2023.04.004_bib14","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/jbmr.3877","article-title":"Secondary fracture prevention: consensus clinical recommendations from a multistakeholder coalition","volume":"35","author":"Conley","year":"2020","journal-title":"J Bone Miner Res"},{"issue":"3","key":"10.1016\/j.jfma.2023.04.004_bib15","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/cpt.2645","article-title":"Reduced all-cause mortality with bisphosphonates among post-fracture osteoporosis patients: a nationwide study and systematic Review","volume":"112","author":"Hsu","year":"2022","journal-title":"Clin Pharmacol Ther"},{"issue":"8","key":"10.1016\/j.jfma.2023.04.004_bib16","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1002\/jbmr.4627","article-title":"The impact of various anti-osteoporosis drugs on all-cause mortality after hip fractures: a nationwide population study","volume":"37","author":"Tai","year":"2022","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.jfma.2023.04.004_bib17","doi-asserted-by":"crossref","first-page":"116216","DOI":"10.1016\/j.bone.2021.116216","article-title":"Treatment of osteoporosis after hip fracture is associated with lower all-cause mortality: a nationwide population study","volume":"154","author":"Tai","year":"2022","journal-title":"Bone"},{"issue":"5","key":"10.1016\/j.jfma.2023.04.004_bib18","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.18632\/aging.203927","article-title":"The association between osteoporosis medications and lowered all-cause mortality after hip or vertebral fracture in older and oldest-old adults: a nationwide population-based study","volume":"14","author":"Li","year":"2022","journal-title":"Aging"},{"issue":"11","key":"10.1016\/j.jfma.2023.04.004_bib19","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data","volume":"43","author":"Quan","year":"2005","journal-title":"Med Care"},{"issue":"28","key":"10.1016\/j.jfma.2023.04.004_bib20","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1002\/sim.6607","article-title":"Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies","volume":"34","author":"Austin","year":"2015","journal-title":"Stat Med"},{"issue":"3","key":"10.1016\/j.jfma.2023.04.004_bib21","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.afos.2020.07.002","article-title":"Comparison of morbidity and mortality of hip and vertebral fragility fractures: which one has the highest burden?","volume":"6","author":"Rizkallah","year":"2020","journal-title":"Osteoporos Sarcopenia"},{"issue":"1","key":"10.1016\/j.jfma.2023.04.004_bib22","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00198-018-4732-1","article-title":"Risk of subsequent fracture after prior fracture among older women","volume":"30","author":"Balasubramanian","year":"2019","journal-title":"Osteoporos Int"},{"issue":"11","key":"10.1016\/j.jfma.2023.04.004_bib23","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1001\/archinte.159.11.1215","article-title":"Vertebral fractures and mortality in older women: a prospective study. Study of Osteoporotic Fractures Research Group","volume":"159","author":"Kado","year":"1999","journal-title":"Arch Intern Med"},{"issue":"7","key":"10.1016\/j.jfma.2023.04.004_bib24","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1359\/jbmr.2003.18.7.1254","article-title":"Association between vertebral fracture and increased mortality in osteoporotic patients","volume":"18","author":"Jalava","year":"2003","journal-title":"J Bone Miner Res"},{"issue":"5","key":"10.1016\/j.jfma.2023.04.004_bib25","doi-asserted-by":"crossref","first-page":"E280","DOI":"10.1097\/BRS.0000000000003264","article-title":"Mortality and cause of death in patients with vertebral fractures: a longitudinal follow-up study using a national sample cohort","volume":"45","author":"Choi","year":"2020","journal-title":"Spine"},{"issue":"1","key":"10.1016\/j.jfma.2023.04.004_bib26","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1186\/s12891-019-2769-8","article-title":"Effect of medications on prevention of secondary osteoporotic vertebral compression fracture, non-vertebral fracture, and discontinuation due to adverse events: a meta-analysis of randomized controlled trials","volume":"20","author":"Jin","year":"2019","journal-title":"BMC Muscoskel Disord"},{"issue":"5","key":"10.1016\/j.jfma.2023.04.004_bib27","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1007\/s00198-021-06264-z","article-title":"Bisphosphonate treatment is associated with decreased mortality rates in patients after osteoporotic vertebral fracture","volume":"33","author":"Iida","year":"2022","journal-title":"Osteoporos Int"},{"issue":"4","key":"10.1016\/j.jfma.2023.04.004_bib28","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1210\/clinem\/dgac636","article-title":"Comparisons between different anti-osteoporosis medications on postfracture mortality: a population-based study","volume":"108","author":"Wu","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.jfma.2023.04.004_bib29","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1007\/s00198-003-1430-3","article-title":"Mortality and morbidity associated with osteoporosis drug treatment following hip fracture","volume":"14","author":"Cree","year":"2003","journal-title":"Osteoporos Int"},{"issue":"3","key":"10.1016\/j.jfma.2023.04.004_bib30","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1007\/s00198-010-1411-2","article-title":"Oral bisphosphonates are associated with reduced mortality after hip fracture","volume":"22","author":"Beaupre","year":"2011","journal-title":"Osteoporos Int"},{"issue":"1","key":"10.1016\/j.jfma.2023.04.004_bib31","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1359\/jbmr.090704","article-title":"Potential mediators of the mortality reduction with zoledronic acid after hip fracture","volume":"25","author":"Colon-Emeric","year":"2010","journal-title":"J Bone Miner Res"},{"issue":"1","key":"10.1016\/j.jfma.2023.04.004_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00198-019-05176-3","article-title":"Algorithm for the management of patients at low, high and very high risk of osteoporotic fractures","volume":"31","author":"Kanis","year":"2020","journal-title":"Osteoporos Int"},{"issue":"S1","key":"10.1016\/j.jfma.2023.04.004_bib33","first-page":"S75","article-title":"Clinical practice guidelines for the prevention and treatment of osteoporosis in Taiwan: 2022 update","volume":"122","author":"Tai","year":"2023","journal-title":"J Formos Med Assoc"},{"issue":"3","key":"10.1016\/j.jfma.2023.04.004_bib34","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/stem.2255","article-title":"Zoledronate attenuates accumulation of DNA damage in mesenchymal stem cells and protects their function","volume":"34","author":"Misra","year":"2016","journal-title":"Stem Cell"},{"issue":"1","key":"10.1016\/j.jfma.2023.04.004_bib35","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.arr.2007.03.002","article-title":"Hormesis in aging","volume":"7","author":"Rattan","year":"2008","journal-title":"Ageing Res Rev"},{"issue":"3","key":"10.1016\/j.jfma.2023.04.004_bib36","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/jcsm.12289","article-title":"Preventing muscle wasting by osteoporosis drug alendronate in vitro and in myopathy models via sirtuin-3 down-regulation","volume":"9","author":"Chiu","year":"2018","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"7","key":"10.1016\/j.jfma.2023.04.004_bib37","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/nm1786","article-title":"Combined treatment with statins and aminobisphosphonates extends longevity in a mouse model of human premature aging","volume":"14","author":"Varela","year":"2008","journal-title":"Nat Med"},{"issue":"12","key":"10.1016\/j.jfma.2023.04.004_bib38","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1002\/acr.21759","article-title":"Does medication adherence itself confer fracture protection? An investigation of the healthy adherer effect in\u00a0observational data","volume":"64","author":"Curtis","year":"2012","journal-title":"Arthritis Care Res"},{"issue":"1","key":"10.1016\/j.jfma.2023.04.004_bib39","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1148\/radiol.2020191294","article-title":"Mortality outcomes of vertebral augmentation (vertebroplasty and\/or balloon Kyphoplasty) for osteoporotic vertebral compression fractures: a systematic Review and meta-analysis","volume":"295","author":"Hinde","year":"2020","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.jfma.2023.04.004_bib40","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s00198-017-4281-z","article-title":"Were VCF patients at higher risk of mortality following the 2009 publication of the vertebroplasty \u201csham\u201d trials?","volume":"29","author":"Ong","year":"2018","journal-title":"Osteoporos Int"},{"issue":"6","key":"10.1016\/j.jfma.2023.04.004_bib41","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1056\/NEJMoa0900429","article-title":"A randomized trial of vertebroplasty for painful osteoporotic vertebral fractures","volume":"361","author":"Buchbinder","year":"2009","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.jfma.2023.04.004_bib42","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1056\/NEJMoa0900563","article-title":"A randomized trial of vertebroplasty for osteoporotic spinal fractures","volume":"361","author":"Kallmes","year":"2009","journal-title":"N Engl J Med"}],"container-title":["Journal of the Formosan Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664623001122?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0929664623001122?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T14:50:43Z","timestamp":1760539843000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0929664623001122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":42,"alternative-id":["S0929664623001122"],"URL":"https:\/\/doi.org\/10.1016\/j.jfma.2023.04.004","relation":{},"ISSN":["0929-6646"],"issn-type":[{"value":"0929-6646","type":"print"}],"subject":[],"published":{"date-parts":[[2023]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Refracture risk and all-cause mortality after vertebral fragility fractures: Anti-osteoporotic medications matter","name":"articletitle","label":"Article Title"},{"value":"Journal of the Formosan Medical Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfma.2023.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Formosan Medical Association. Published by Elsevier Taiwan LLC.","name":"copyright","label":"Copyright"}]}}